Answers are grounded in this paper and cite their sources.
Background: Contract manufacturing organizations (CMOs) produce a large and growing share of the world's medicines, yet they remain over-represented in regulatory enforcement. This study asks which compliance and quality assurance problems recur at CMOs, why they recur, and what practical controls would reduce them. Methods: A mixed-methods design combined (i) a retrospective classification of 214 USFDA Warning Letters issued to contract manufacturing sites between January 2019 and December 2025 into eight deficiency categories, and (ii) a cross-sectional online survey of 88 quality assurance, quality control and regulatory affairs professionals with CMO or CDMO experience. Data were analysed with descriptive statistics, Pareto analysis, cross-tabulation and chi-square testing (α = 0.05). Results: Data integrity and computerised systems were cited in 68.7% of letters (76% in 2025, up from 61% in 2019-20), followed by laboratory controls and OOS investigation (60.3%). Survey respondents attributed data integrity risk mainly to inadequate audit trail review resourcing (69.3%) and shared logins (61.4%). Only 35.2% performed effectiveness checks on all CAPAs, and fewer than half had quality agreements that set change-notification (44.3%) or deviation escalation (40.9%) timelines. Self-assessed quality system maturity rose with organization size in every element measured; 39.4% of small-organization respondents scored below the scale midpoint on a composite index, against 4.2% of large-organization respondents. Conclusions: The leading problems are systemic (resourcing, system design, and sponsor-CMO governance) rather than individual. Four tools are proposed: a CMO-specific risk-scoring matrix, a model quality technical agreement clause set, a four-layer data integrity governance model and a ten-point self-inspection checklist, delivered through a phased twelve-month roadmap sized for resource-constrained CMOs.
No takes yet. Share an insight, caveat, or question.
Sonwane et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: